Molly Downey

Multiomics analysis of serial PARP inhibitor treated metastatic TNBC inform on rational combination therapies

P. Spellman, G. Mills, K. Chin, 2021, npj Precision Oncology.

Multi-omics analysis of serial samples from metastatic TNBC patients on PARP inhibitor monotherapy provide insight into rational PARP inhibitor therapy combinations

P. Spellman, K. Chin, L. Coussens, 2020, medRxiv.

Characterizing advanced breast cancer heterogeneity and treatment resistance through serial biopsies and comprehensive analytics

Laura M. Heiser, G. Mills, J. Gray, 2021, npj Precision Oncology.